April 15, 2021
Article
Antimicrobials were commonly prescribed during the first wave of the pandemic, and clinicians were successfully guided by antimicrobial stewardship programs.
Increased facility-level vaccine coverage amongst residents and staff was associated with lower cases in the latter population.
April 14, 2021
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) met today to discuss the blood clots’ issue and offered guidance on heparin usage in these cases.
Video
An interventional cardiologist discusses the observed cases of cerebral venous thrombosis in women administered the Johnson & Johnson COVID-19 vaccine.
The two measures were shown to prevent viral outbreaks if at least 60% of a population followed them.
April 13, 2021
The monoclonal antibody cocktail reduced symptomatic infections by 72% in the first week and 93% in following weeks.
In a press conference this morning, leadership of the FDA and CDC discussed why they made the decision on this vaccine and announced an ACIP meeting will be held tomorrow to review the data from the adverse events.
The federal agencies will advise states withhold administration of the Johnson & Johnson one-shot product while investigating risk of a rare blood clot disorder.
Our editor-in-chief writes on the role caregivers play in informing the public on the perks of a more vaccinated population.
April 12, 2021
New cohort analyses show the popular UK variant is linked to a higher viral load, though patients have not experienced worse likelihood of outcomes.
